Stockreport

MAIA Biotechnology to Present at the BIO International Convention 2024

MAIA Biotechnology, Inc.  (MAIA) 
PDF CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, announce [Read more]